Your browser doesn't support javascript.
loading
Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆.
Lacouture, M E; Sibaud, V; Gerber, P A; van den Hurk, C; Fernández-Peñas, P; Santini, D; Jahn, F; Jordan, K.
Afiliação
  • Lacouture ME; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Sibaud V; Department of Oncodermatology, Claudius Regaud Institute, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
  • Gerber PA; Department of Dermatology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
  • van den Hurk C; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.
  • Fernández-Peñas P; Department of Dermatology, The University of Sydney, Westmead Hospital, Sydney, Australia.
  • Santini D; Arcispedale Santa Maria Nuova di Reggio Emilia, Reggio Emilia, Italy; Department of Medical Oncology, University Campus Bio-Medico, Rome, Italy.
  • Jahn F; Department of Internal Medicine IV, Hematology, Oncology, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
  • Jordan K; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Ann Oncol ; 32(2): 157-170, 2021 02.
Article em En | MEDLINE | ID: mdl-33248228
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antineoplásicos Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antineoplásicos Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article